[Business Wire] – Gilead Sciences, Inc. today announced that 10 abstracts describing the company’s investigational agents for several hematological malignancies have been selected for presentation at the Annual Meeting of the American Society . . . → Read More: Gilead Sciences Inc. (NASDAQ:GILD) | Gilead to Present Data on Oncology Pipeline at American Society of Hematology Annual Meeting Similar posts: Pfizer 3rd-qtr profit beats estimates; oncology drugs shine – Pfizer Inc. (NYSE:PFE) Exxon Mobil Corporation (NYSE:XOM) – Stay granted in case over Exxon pipeline spill Data from Merck’s Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual Meeting – Merck & Co. Inc. (NYSE:MRK)